About Allogene (ALLO)
Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more
- USD2.86
- USD2.86
- USD2.74
- USD6.89
- -26.50%
- 0M
- 808.01k
- 1.97M
- 524M
- 2.23
- -55.90%
Stock News
2 hours ago
Veritone, Inc. (NASDAQ:VERI) Q1 2024 Earnings Call Transcript
Yahoo
3 hours ago
Hidden Gems: Unveiling the 10 Stocks on Hedge Funds’ Radar
Yahoo
3 hours ago
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2024 Earnings Call Transcript
Yahoo
3 hours ago
Ameresco, Inc. (NYSE:AMRC) Q1 2024 Earnings Call Transcript
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
